Table of Contents Author Guidelines Submit a Manuscript
International Journal of Microbiology
Volume 2010, Article ID 874189, 15 pages
http://dx.doi.org/10.1155/2010/874189
Research Article

Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992–2008)

1National Reference Center for Streptococci, Institute of Medical Microbiology, University Hospital (RWTH), 52074 Aachen, Germany
2Wyeth Vaccines Research, Coeur Défense-Tour A, 110 esplanade du Général de Gaulle, 92931 Paris la Défense Cedex, France

Received 1 April 2010; Accepted 21 April 2010

Academic Editor: Todd R. Callaway

Copyright © 2010 Matthias Imöhl et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Austrian, “Pneumococcus: the first one hundred years,” Reviews of Infectious Diseases, vol. 3, no. 2, pp. 183–189, 1981. View at Google Scholar · View at Scopus
  2. D. R. Feikin and K. P. Klugman, “Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines,” Clinical Infectious Diseases, vol. 35, no. 5, pp. 547–555, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. M. R. Jacobs, C. E. Good, B. Beall, S. Bajaksouzian, A. R. Windau, and C. G. Whitney, “Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience,” Journal of Clinical Microbiology, vol. 46, no. 3, pp. 982–990, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. A. Fenoll, J. J. Granizo, and J. J. Granizo, “Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007,” Journal of Clinical Microbiology, vol. 47, no. 4, pp. 1012–1020, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. R. R. Reinert, “Pneumococcal conjugate vaccines—a European perspective,” International Journal of Medical Microbiology, vol. 294, no. 5, pp. 277–294, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. D. R. Feikin, K. P. Klugman, R. R. Facklam, E. R. Zell, A. Schuchat, and C. G. Whitney, “Increased prevalence of pediatric pneumococcal serotypes in elderly adults,” Clinical Infectious Diseases, vol. 41, no. 4, pp. 481–487, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. M. Imöhl, R. R. Reinert, and M. van der Linden, “Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states,” International Journal of Medical Microbiology, vol. 300, no. 4, pp. 237–247, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. R. R. Reinert, A. Queck, A. Kaufhold, M. Kresken, and R. Lütticken, “Antimicrobial resistance and type distribution of Streptococcus pneumoniae isolates causing systemic infections in Germany, 1992–1994,” Clinical Infectious Diseases, vol. 21, no. 6, pp. 1398–1401, 1995. View at Google Scholar · View at Scopus
  9. R. R. Reinert, A. Al-Lahham, and A. Al-Lahham, “Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany,” Journal of Antimicrobial Chemotherapy, vol. 49, no. 1, pp. 61–68, 2002. View at Google Scholar · View at Scopus
  10. R. Von Kries, A. Siedler, H. J. Schmitt, and R. R. Reinert, “Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines,” Clinical Infectious Diseases, vol. 31, no. 2, pp. 482–487, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. R. R. Reinert, S. Haupts, M. van der Linden, C. Heeg, M. Y. Cil, A. Al-Lahham, and D. S. Fedson, “Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001–2003,” Clinical Microbiology and Infection, vol. 11, no. 12, pp. 985–991, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. A. Kaufhold, R. Lütticken, and J. Henrichsen, “Capsular types and antibiotic susceptibility of Streptococcus pneumoniae isolated from patients with systemic infections in West Germany,” European Journal of Clinical Microbiology, vol. 6, no. 6, pp. 696–697, 1987. View at Google Scholar · View at Scopus
  13. S. Rückinger, R. von Kries, R. R. Reinert, M. van der Linden, and A. Siedler, “Childhood invasive pneumococcal disease in Germany between 1997 and 2003: variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination,” Vaccine, vol. 26, no. 32, pp. 3984–3986, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. D. Foster, K. Knox, and K. Knox, “Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England,” Journal of Medical Microbiology, vol. 57, no. 4, pp. 480–487, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. J. Flamaing, J. Verhaegen, J. Vandeven, N. Verbiest, and W. E. Peetermans, “Pneumococcal bacteraemia in Belgium (1994–2004): the pre-conjugate vaccine era,” Journal of Antimicrobial Chemotherapy, vol. 61, no. 1, pp. 143–149, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. H. B. Konradsen and M. S. Kaltoft, “Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance,” Clinical and Diagnostic Laboratory Immunology, vol. 9, no. 2, pp. 358–365, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Imöhl, R. R. Reinert, and M. van der Linden, “Adult invasive pneumococcal disease between 2003 and 2006 in North-Rhine Westphalia, Germany: serotype distribution before recommendation for general pneumococcal conjugate vaccination for children <2 years of age,” Clinical Microbiology and Infection, vol. 15, no. 11, pp. 1008–1012, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. M. C. de Cunto Brandileone, D. V. V. Simonsen, S. Tadeu Casagrande et al., “Characteristics of isolates Streptococcus pneumoniae from middle-aged and elderly adults in Brazil: capsular serotypes and antimicrobial sensitivity to invasive infections,” Brazilian Journal of Infectious Diseases, vol. 2, pp. 90–96, 1998. View at Google Scholar
  19. J. F. Plouffe, S. K. Moore, R. Davis, and R. R. Facklam, “Serotypes of Streptococcus pneumoniae blood culture isolates from adults in Franklin County, Ohio,” Journal of Clinical Microbiology, vol. 32, no. 6, pp. 1606–1607, 1994. View at Google Scholar · View at Scopus
  20. C. G. Whitney, M. M. Farley, and M. M. Farley, “Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States,” New England Journal of Medicine, vol. 343, no. 26, pp. 1917–1924, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Lütticken and A. Kaufhold, “Serotypen und Antibiotikaempfindlichkeit von Streptococcus pneumoniae (Pneumokokken) im Raum Köln,” Immunitat und Infektion, vol. 13, no. 3, pp. 99–107, 1985. View at Google Scholar · View at Scopus
  22. L. A. Hicks, L. H. Harrison, and L. H. Harrison, “Incidence of pneumococcal disease due to non- pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004,” Journal of Infectious Diseases, vol. 196, no. 9, pp. 1346–1354, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. R. R. Reinert, “The antimicrobial resistance profile of Streptococcus pneumoniae,” Clinical Microbiology and Infection, vol. 15, supplement 3, pp. 7–11, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. W. P. Hausdorff, “Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution,” European Journal of Pediatrics, vol. 161, supplement 2, pp. S135–S139, 2002. View at Google Scholar · View at Scopus
  25. S. Rückinger, M. van der Linden, R. R. Reinert, R. von Kries, F. Burckhardt, and A. Siedler, “Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany,” Vaccine, vol. 27, no. 31, pp. 4136–4141, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. S. I. Aguiar, I. Serrano, F. R. Pinto, J. Melo-Cristino, and M. Ramirez, “Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine,” Clinical Microbiology and Infection, vol. 14, no. 9, pp. 835–843, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. R. Dias and M. Caniça, “Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine,” FEMS Immunology and Medical Microbiology, vol. 51, no. 1, pp. 35–42, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. A. Lepoutre, E. Varon, S. Georges, L. Gutmann, and D. Lévy-Bruhl, “Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001–2006,” Euro Surveillance, vol. 13, no. 35, 2008. View at Google Scholar
  29. R. Mera, L. A. Miller, T. R. Fritsche, and R. N. Jones, “Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine,” Microbial Drug Resistance, vol. 14, no. 2, pp. 101–107, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. D. Akduman, J. M. Ehret, and F. N. Judson, “Comparison of secular trends in pneumococcal serotypes causing invasive disease in Denver, Colorado (1971–2004) and serotype coverage by marketed pneumococcal vaccines,” Clinical Microbiology and Infection, vol. 12, no. 11, pp. 1141–1143, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. W. P. Hausdorff, J. Bryant, P. R. Paradiso, and G. R. Siber, “Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use—part I,” Clinical Infectious Diseases, vol. 30, no. 1, pp. 100–121, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. Ständige Impfkommission (STIKO), “Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut (Stand Juli 2006):Begründungen zur allgemeinen Empfehlung der Impfungen gegen Pneumokokken- und Meningokokken im Säuglings- und Kindesalter,” Epidemiolgisches Bulletin, vol. 30, pp. 255–260, 2006. View at Google Scholar